Sania Therapeutics is a London-based biotech startup founded in 2021. The company's slogan "Precision genetic neuromodulation for neural circuit dysfunction" encapsulates its mission to develop precision therapeutics for individuals suffering from diseases related to dysfunctional neural circuits. Specializing in the biotechnology, health care, and health and wellness industries, Sania has recently received a $5.05M Seed Round investment on 23 March 2022. Although the specific investors for this round are not disclosed, this investment underscores the potential seen in Sania's approach to addressing complex neural circuit dysfunctions. With its focus on precision and patient-centered design, Sania Therapeutics aims to make a significant impact in transforming the lives of those affected by neural circuit disorders. Based in the United Kingdom, the company's innovative approach holds promise in the evolving landscape of biotech and healthcare startups.
Sania Therapeutics
Precision genetic neuromodulation for neural circuit dysfunction
London, United Kingdom
22 employees
Seed
Total: $5.05M
Biotechnology, Health Care +1
General Information
Get notified when Sania Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Sania Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United Kingdom Market
Biotechnology
About Sania Therapeutics
Taxonomy: Precision genetic neuromodulation, Neural circuit dysfunction, Therapeutics, Biotech company, Diseases, London, Patients, Neuroscience, Neurological disorders, Precision medicine, Genetic therapy, Healthcare innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | - | 23 Mar 2022 |
Sania Therapeutics Alternatives & Competitors
Achieving Unmatched Precision in Genetic Mutation Detection for Life-Saving Accuracy
Edit the message. Rewrite the future. Pioneering RNA editing to deliver the future of medicine.
A population genetics company identifying the genetic causes of major diseases using a unique and ri...
FAQ About Sania Therapeutics
Don't just browse. Track.
Signal Tracker monitors Sania Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
